peri-implantitis (inflammation with bone affection)
Conditions
Interventions
Group 1: Ultrasonic scaling and topical administration of a 10% povidone-iodine (PVP-iodine) solution and 10% PVP-iodine gel, repetitions initially weekly, then every second and third week and finally
Sponsors
Zentrum für Zahnmedizin. Klinik für Präventivzahnmedizin, Parodontologie und Kariologie
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: • Informed Consent as documented by signature • Systemically healthy subjects • At least one dental implant with periimplantitis in terms of a progressive bone loss, probing pocket depth of = 6 mm and bleeding on probing and a vertical bone loss of max. 5 mm. • Fixed prosthetics
Exclusion criteria
Exclusion criteria: • Patients with untreated periodontitis • Heavy smokers (> 20 cigarettes) • Pregnant or nursing women. • Patients with antibiotic therapy within the last 6 months • Patients with periimplantitis therapy within the last 3 months • Subjects with an allergy to either PVP-iodine or chlorhexidine • Anti-coagulated patients (exception: intake of 100 mg acetylsalicyl acid per day)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome variable is the periimplant pocket depth in combination with bleeding-on-probing 24 weeks after baseline examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are the change in plaque accumulation (Plaque index), radiographic bone level and the taxa of key bacteria species 2, 4, 6, 9, 12 and 24 weeks after baseline examination. | — |
Countries
Switzerland
Contacts
Public ContactPhilipp Sahrmann
Zentrum für Zahnmedizin. Klinik für Präventivzahnmedizin, Parodontologie und Kariologie
Outcome results
None listed